ArticleOncotarget2015

Targeting the membrane-anchored serine protease testisin with a novel engineered anthrax toxin prodrug to kill tumor cells and reduce tumor burden.

Erik W Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.